Principales conclusions et analyse des parts de marché des thérapies antisens et ARN interférent d'ici 2025-2031
Antisense and RNAi Therapeutics Market Report Analysis
Antisense and RNAi Therapeutics Market
-
CAGR (2025 - 2031)7.50% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals
- Benitec Biopharma Ltd.
- Quark Pharmaceuticals
- Ionis Pharmaceuticals
- Astellas Pharma Inc
- Marina Biosciences
- Sanofi S
- Dicerna Pharmaceuticals
- Tekmira Pharmaceuticals
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Type
- interférence ARN
- ARN antisens
By Voie d'administration
- administration pulmonaire
- injections intraveineuses
- intradermiques
- intrapéritonéales
- topiques
- autres
By Application
- maladies infectieuses
- maladies cardiovasculaires
- cancer
- troubles neurologiques
- autres
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Get Free Sample For